You have 9 free searches left this month | for more free features.

neuromuscular blocking agent

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Remimazolam and Remifentanil Without Neuromuscular Blocking

Completed
  • Myoma;Uterus
  • +2 more
  • Seongnam, Korea, Republic of
    Seoul National University Bundang Hospital
Apr 21, 2022

Brain Tumor Trial in Seoul (Arm I (MEP))

Recruiting
  • Brain Tumor
  • Arm I (MEP)
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Apr 26, 2021

Obesity, Bariatric Surgery Candidate, Intubation Complication Trial in Toulouse (Remifentanil Injection, Remifentanil Injection

Recruiting
  • Obesity
  • +2 more
  • Remifentanil Injection
  • Remifentanil Injection plus 30%
  • Toulouse, France
    Hospital University of Toulouse
May 30, 2022

"Effects of Neuromuscular Blocking Agents on End Expiratory Lung

Completed
  • ARDS
  • Neuromuscular Blockade
    • Monza, Lombardia, Italy
      ASST Monza
    Apr 27, 2022

    Respiratory Failure, Respiratory Infection, Aspiration Pneumonia Trial in Boston (Neuromuscular Blocking Agents, Anesthetic

    Terminated
    • Respiratory Failure
    • +5 more
    • Neuromuscular Blocking Agents
    • Anesthetic Adjuncts
    • Boston, Massachusetts
    • +1 more
    Jan 31, 2023

    Neuromuscular Blockade Reversal Agent, Sugammadex, Neostigmine Trial in Seongnam-si (Sugammadex, Neostigmine)

    Completed
    • Neuromuscular Blockade Reversal Agent
    • +4 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Dec 22, 2020

    Neuromuscular Blocking Drugs and Reversal

    Completed
    • Neuromuscular Blockade
    • +2 more
    • Neuromuscular blocking agents
    • Boston, Massachusetts
    • +1 more
    Aug 19, 2021

    Neostigmine, Neuromuscular Blocking Agents, Muscle Weakness Trial in Sorocaba (Reversal of moderate neuromuscular blockade,

    Completed
    • Neostigmine
    • +2 more
    • Reversal of moderate neuromuscular blockade
    • +3 more
    • Sorocaba, SP, Brazil
      Santa Lucina Hospital
    May 12, 2022

    Urinary Retention Postoperative, Laparoscopic Cholecystectomy, Neuromuscular Blockade Trial (Neostigmine, Sugammadex)

    Not yet recruiting
    • Urinary Retention Postoperative
    • +6 more
    • (no location specified)
    Mar 20, 2023

    Neuromuscular Blockade, Anesthesia, Surgery Trial in Salt Lake City (BX1000, Rocuronium Bromide)

    Recruiting
    • Neuromuscular Blockade
    • +2 more
    • Salt Lake City, Utah
      Research Center
    Jan 6, 2023

    Thyroid Diseases, Surgical Injury, Nerve Monitoring Trial in Seoul (Neostigmine, Normal saline)

    Completed
    • Thyroid Diseases
    • +2 more
    • Seoul, Korea, Republic of
      Seoul Metropolitan Government Seoul National University Boramae
    Mar 3, 2022

    Allergy Trial in Jacksonville (Skin Testing)

    Completed
    • Allergy
    • Skin Testing
    • Jacksonville, Florida
      Mayo Clinic
    Feb 1, 2022

    Shoulder Pain, Anesthesia Trial in Leuven (Deep neuromuscular block, Moderate neuromuscular block, Neuromuscular Blocking Agents

    Recruiting
    • Shoulder Pain
    • Anesthesia
    • Deep neuromuscular block
    • +2 more
    • Leuven, Vlaams-Brabant, Belgium
      University Hospitals Leuven
    Aug 9, 2022

    Neuromuscular Recovery in Surgical Patients Using Machine

    Not yet recruiting
    • Residual Paralysis, Post Anesthesia
    • +2 more
      • Ulm, Baden-Württemberg, Germany
      • +1 more
      Jul 20, 2022

      Neuromuscular Block, Residual Trial in Seoul (Sugammadex, Neostigmine)

      Recruiting
      • Neuromuscular Block, Residual
      • Seoul, Jongrogu, Korea, Republic of
        Seoul National University Hospital
      Feb 9, 2023

      Hypoxemia Trial in France (Rocuronium, Sodium chloride 0.9%)

      Recruiting
      • Hypoxemia
      • Créteil, France
      • +5 more
      Jan 26, 2022

      Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex

      Completed
      • Anesthesia, General
      • Neuromuscular Blockade
      • Sugammadex Injection 2mg/kg
      • +3 more
      • Seoul, Jongro Gu, Korea, Republic of
        SNUH
      Oct 20, 2022

      Rocuronium, Muscle Weakness, General Anaesthesia Trial in Zagreb (Rocuronium, General anesthesia for surgery)

      Enrolling by invitation
      • Rocuronium
      • +2 more
      • Zagreb, Croatia
        UHCZagreb
      Mar 6, 2022

      Neuromuscular Blockade in Intentive Care Unit,Observational

      Completed
      • Critical Care
      • +2 more
      • Neuromuscular Blocking Agents
      • Argenteuil, France
      • +10 more
      Dec 15, 2021

      Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane

      Recruiting
      • Metastatic Breast Cancer
      • Enobosarm & Abemaciclib Combo
      • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
      • Chandler, Arizona
      • +29 more
      Feb 1, 2023

      Sugammadex Trial in Taoyuan (Neostigmine and Sugammadex)

      Recruiting
      • Sugammadex
      • Neostigmine and Sugammadex
      • Taoyuan, Taiwan
        Yu-Hsun-Tsai
      Mar 8, 2022

      DLBCL Trial in San Juan (PF-07901801, Tafasitamab, Lenalidomide)

      Not yet recruiting
      • Diffuse Large B-Cell Lymphoma
      • San Juan, Puerto Rico
        Auxilio Mutuo Cancer Center
      Jan 19, 2023

      Respiratory Distress Syndrome, Adult Trial in United States (Hypothermia, Neuromuscular Blocking Agents, Standard of care)

      Recruiting
      • Respiratory Distress Syndrome, Adult
      • Hypothermia
      • +2 more
      • Atlanta, Georgia
      • +14 more
      Oct 5, 2022

      COVID-19 Acute Respiratory Distress Syndrome, Sedation Complication, ICU Acquired Weakness Trial (muscle relaxation)

      Not yet recruiting
      • COVID-19 Acute Respiratory Distress Syndrome
      • +2 more
      • muscle relaxation
      • (no location specified)
      Jun 9, 2021

      Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex

      Completed
      • Anesthesia, General
      • Neuromuscular Blockade
      • Sugammadex Injection 2mg/kg
      • +3 more
      • Seoul, Jongro Gu, Korea, Republic of
        SNUH
      Feb 8, 2022